1. Home
  2. CRGX vs ZVIA Comparison

CRGX vs ZVIA Comparison

Compare CRGX & ZVIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRGX
  • ZVIA
  • Stock Information
  • Founded
  • CRGX 2021
  • ZVIA 2007
  • Country
  • CRGX United States
  • ZVIA United States
  • Employees
  • CRGX N/A
  • ZVIA N/A
  • Industry
  • CRGX
  • ZVIA Beverages (Production/Distribution)
  • Sector
  • CRGX
  • ZVIA Consumer Staples
  • Exchange
  • CRGX Nasdaq
  • ZVIA Nasdaq
  • Market Cap
  • CRGX 213.5M
  • ZVIA 196.2M
  • IPO Year
  • CRGX 2023
  • ZVIA 2021
  • Fundamental
  • Price
  • CRGX $4.52
  • ZVIA $3.29
  • Analyst Decision
  • CRGX Hold
  • ZVIA Hold
  • Analyst Count
  • CRGX 7
  • ZVIA 2
  • Target Price
  • CRGX $5.33
  • ZVIA $3.38
  • AVG Volume (30 Days)
  • CRGX 3.0M
  • ZVIA 1.0M
  • Earning Date
  • CRGX 08-11-2025
  • ZVIA 08-06-2025
  • Dividend Yield
  • CRGX N/A
  • ZVIA N/A
  • EPS Growth
  • CRGX N/A
  • ZVIA N/A
  • EPS
  • CRGX N/A
  • ZVIA N/A
  • Revenue
  • CRGX N/A
  • ZVIA $154,273,000.00
  • Revenue This Year
  • CRGX $57.81
  • ZVIA $5.70
  • Revenue Next Year
  • CRGX N/A
  • ZVIA $6.76
  • P/E Ratio
  • CRGX N/A
  • ZVIA N/A
  • Revenue Growth
  • CRGX N/A
  • ZVIA N/A
  • 52 Week Low
  • CRGX $3.00
  • ZVIA $0.76
  • 52 Week High
  • CRGX $25.45
  • ZVIA $4.99
  • Technical
  • Relative Strength Index (RSI)
  • CRGX 54.72
  • ZVIA 57.29
  • Support Level
  • CRGX $4.40
  • ZVIA $2.60
  • Resistance Level
  • CRGX $4.63
  • ZVIA $3.46
  • Average True Range (ATR)
  • CRGX 0.07
  • ZVIA 0.20
  • MACD
  • CRGX -0.01
  • ZVIA 0.03
  • Stochastic Oscillator
  • CRGX 34.29
  • ZVIA 79.65

About CRGX CARGO Therapeutics Inc.

Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platforms, and manufacturing are designed to directly address the limitations of approved chimeric antigen receptor (CAR) T-cell therapies. Its product includes CRG-023, an investigational tri-specific CAR T designed to address several known causes of relapse associated with existing CAR T-cell therapies such as loss of tumor antigen expression, loss of co-stimulation (e.g., via CD58/CD2 signaling) and T cell exhaustion. CRG-023 is designed to target the B-cell lineage antigens (CD19, CD20, CD22) via tri-cistronic expression of three distinct CARs from a single lentiviral vector.

About ZVIA Zevia PBC

Zevia PBC is a beverage company disrupting the liquid refreshment beverage industry through refreshing, zero-calorie, zero-sugar, naturally sweetened beverages that are all Non-GMO Project Verified. It offers a platform of products that include a variety of flavors across Soda, Energy Drinks, Organic Tea, Mixers, Kidz drinks, and Sparkling Water. Its products are distributed across the U.S. and Canada through a network of retailers in the food, drug, mass, natural, and e-commerce channels. The company derives a majority of its revenue from the United States.

Share on Social Networks: